The Wnt/β-catenin signaling pathway in liver biology and disease

References

• Sharma RP, Chopra VL. Effect of the Wingless (wg1) mutation on wing and haltere development in Drosophila melanogaster. Dev. Biol.48(2), 461–465 (1976).
   PubMed Web of Science ®Google Scholar
• Nusse R, Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell31(1), 99–109 (1982).
   PubMed Web of Science ®Google Scholar
• Rijsewijk F, Schuermann M, Wagenaar E et al. The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell50(4), 649–657 (1987).
   PubMed Web of Science ®Google Scholar
• Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell. Dev. Biol.20, 781–810 (2004).
   PubMed Web of Science ®Google Scholar
• Gordon MD, Nusse R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J. Biol. Chem.281(32), 22429–22433 (2006).
   PubMed Web of Science ®Google Scholar
• He X, Semenov M, Tamai K, Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/β-catenin signaling: arrows point the way. Development131(8), 1663–1677 (2004).
   PubMed Web of Science ®Google Scholar
• MacDonald BT, Tamai K, He X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev. Cell.17(1), 9–26 (2009).
   PubMed Web of Science ®Google Scholar
• Zeng G, Awan F, Otruba W et al. Wnt’er in liver: expression of Wnt and Frizzled genes in mouse. Hepatology45(1), 195–204 (2007).
   PubMed Web of Science ®Google Scholar
• Panakova D, Sprong H, Marois E, Thiele C, Eaton S. Lipoprotein particles are required for Hedgehog and Wingless signalling. Nature435(7038), 58–65 (2005).
   PubMed Web of Science ®Google Scholar
• Franch-Marro X, Marchand O, Piddini E et al. Glypicans shunt the Wingless signal between local signalling and further transport. Development132(4), 659–666 (2005).
   PubMed Web of Science ®Google Scholar
• Nelson WJ, Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways. Science303(5663), 1483–1487 (2004).
   PubMed Web of Science ®Google Scholar
• Drees F, Pokutta S, Yamada S, Nelson WJ, Weis WI. α-catenin is a molecular switch that binds E-cadherin-β-catenin and regulates actin-filament assembly. Cell123(5), 903–915 (2005).
   PubMed Web of Science ®Google Scholar
• Yamada S, Pokutta S, Drees F, Weis WI, Nelson WJ. Deconstructing the cadherin–catenin–actin complex. Cell123(5), 889–901 (2005).
   PubMed Web of Science ®Google Scholar
• Kam Y, Quaranta V. Cadherin-bound β-catenin feeds into the Wnt pathway upon adherens junctions dissociation: evidence for an intersection between β-catenin pools. PLoS ONE4(2), e4580 (2009).
   PubMed Web of Science ®Google Scholar
• Monga SP, Mars WM, Pediaditakis P et al. Hepatocyte growth factor induces Wnt-independent nuclear translocation of β-catenin after Met-β-catenin dissociation in hepatocytes. Cancer Res.62(7), 2064–2071 (2002).
   PubMed Web of Science ®Google Scholar
• Zeng G, Apte U, Micsenyi A, Bell A, Monga SP. Tyrosine residues 654 and 670 in β-catenin are crucial in regulation of Met-β-catenin interactions. Exp. Cell. Res.312(18), 3620–3630 (2006).
   PubMed Web of Science ®Google Scholar
• Semenov MV, Habas R, Macdonald BT, He X. SnapShot: noncanonical Wnt signaling pathways. Cell131(7), 1378 (2007).
   PubMed Web of Science ®Google Scholar
• Tada M, Kai M. Noncanonical Wnt/PCP signaling during vertebrate gastrulation. Zebrafish6(1), 29–40 (2009).
   PubMed Web of Science ®Google Scholar
• Jessen JR. Noncanonical Wnt signaling in tumor progression and metastasis. Zebrafish6(1), 21–28 (2009).
   PubMed Web of Science ®Google Scholar
• Wada H, Okamoto H. Roles of noncanonical Wnt/PCP pathway genes in neuronal migration and neurulation in zebrafish. Zebrafish6(1), 3–8 (2009).
   PubMed Web of Science ®Google Scholar
• Nusslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature287(5785), 795–801 (1980).
   PubMed Web of Science ®Google Scholar
• Nejak-Bowen K, Monga SP. Wnt/β-catenin signaling in hepatic organogenesis. Organogenesis4(2), 92–99 (2008).
   PubMedGoogle Scholar
• Si-Tayeb K, Lemaigre FP, Duncan SA. Organogenesis and development of the liver. Dev. Cell.18(2), 175–189 (2010).
   PubMed Web of Science ®Google Scholar
• Chu J, Sadler KC. New school in liver development: lessons from zebrafish. Hepatology50(5), 1656–1663 (2009).
   PubMed Web of Science ®Google Scholar
• Lemaigre FP. Mechanisms of liver development: concepts for understanding liver disorders and design of novel therapies. Gastroenterology137(1), 62–79 (2009).
   PubMed Web of Science ®Google Scholar
• Sekine S, Gutierrez PJ, Lan BY, Feng S, Hebrok M. Liver-specific loss of β-catenin results in delayed hepatocyte proliferation after partial hepatectomy. Hepatology45(2), 361–368 (2007).
   PubMed Web of Science ®Google Scholar
• Tan X, Behari J, Cieply B, Michalopoulos GK, Monga SP. Conditional deletion of β-catenin reveals its role in liver growth and regeneration. Gastroenterology131(5), 1561–1572 (2006).
   PubMed Web of Science ®Google Scholar
• Tan X, Apte U, Micsenyi A et al. Epidermal growth factor receptor: a novel target of the Wnt/β-catenin pathway in liver. Gastroenterology129(1), 285–302 (2005).
   PubMed Web of Science ®Google Scholar
• Nejak-Bowen KN, Thompson MD, Singh S et al. Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant β-catenin. Hepatology51(5), 1603–1613 (2010).
   PubMed Web of Science ®Google Scholar
• Apte U, Singh S, Zeng G et al. β-catenin activation promotes liver regeneration after acetaminophen-induced injury. Am. J. Pathol.175(3), 1056–1065 (2009).
   PubMed Web of Science ®Google Scholar
• Jungermann K, Katz N. Functional hepatocellular heterogeneity. Hepatology2(3), 385–395 (1982).
   PubMed Web of Science ®Google Scholar
• Jungermann K, Katz N. Functional specialization of different hepatocyte populations. Physiol. Rev.69(3), 708–764 (1989).
   PubMed Web of Science ®Google Scholar
• Katz NR. Metabolic heterogeneity of hepatocytes across the liver acinus. J. Nutr.122(3 Suppl.), 843–849 (1992).
   PubMed Web of Science ®Google Scholar
• Brosnan ME, Brosnan JT. Hepatic glutamate metabolism: a tale of 2 hepatocytes. Am. J. Clin. Nutr.90(3), 857S–861S (2009).
   PubMed Web of Science ®Google Scholar
• Loeppen S, Schneider D, Gaunitz F et al. Overexpression of glutamine synthetase is associated with β-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital. Cancer Res.62(20), 5685–5688 (2002).
   PubMed Web of Science ®Google Scholar
• Nicholes K, Guillet S, Tomlinson E et al. A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. Am. J. Pathol.160(6), 2295–2307 (2002).
   PubMed Web of Science ®Google Scholar
• Benhamouche S, Decaens T, Godard C et al. Apc tumor suppressor gene is the ‘zonation-keeper’ of mouse liver. Dev. Cell.10(6), 759–770 (2006).
   PubMed Web of Science ®Google Scholar
• Sekine S, Lan BY, Bedolli M, Feng S, Hebrok M. Liver-specific loss of β-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice. Hepatology43(4), 817–825 (2006).
   PubMed Web of Science ®Google Scholar
• Burke ZD, Reed KR, Phesse TJ et al. Liver zonation occurs through a β-catenin-dependent, c-Myc-independent mechanism. Gastroenterology136(7), 2316–2324, e2311–e2313 (2009).
   PubMed Web of Science ®Google Scholar
• Colletti M, Cicchini C, Conigliaro A et al. Convergence of Wnt signaling on the HNF4α-driven transcription in controlling liver zonation. Gastroenterology137(2), 660–672 (2009).
   PubMed Web of Science ®Google Scholar
• Danielson PB. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr. Drug Metab.3(6), 561–597 (2002).
   PubMed Web of Science ®Google Scholar
• Kohle C, Bock KW. Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor. Biochem. Pharmacol.77(4), 689–699 (2009).
   PubMed Web of Science ®Google Scholar
• Loeppen S, Koehle C, Buchmann A, Schwarz M. A β-catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors. Carcinogenesis26(1), 239–248 (2005).
   PubMed Web of Science ®Google Scholar
• Gooding PE, Chayen J, Sawyer B, Slater TF. Cytochrome P-450 distribution in rat liver and the effect of sodium phenobarbitone administration. Chem. Biol. Interact.20(3), 299–310 (1978).
   PubMed Web of Science ®Google Scholar
• Bühler R, Lindros KO, Nordling A, Johansson I, Ingelman-Sundberg M. Zonation of cytochrome P450 isozyme expression and induction in rat liver. Eur. J. Biochem.204(1), 407–412 (1992).
   PubMedGoogle Scholar
• Hailfinger S, Jaworski M, Braeuning A, Buchmann A, Schwarz M. Zonal gene expression in murine liver: lessons from tumors. Hepatology43(3), 407–414 (2006).
   PubMed Web of Science ®Google Scholar
• Braeuning A, Sanna R, Huelsken J, Schwarz M. Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1. Drug Metab. Dispos.37(5), 1138–1145 (2009).
   PubMed Web of Science ®Google Scholar
• Giera S, Braeuning A, Kohle C et al. Wnt/β-catenin signaling activates and determines hepatic zonal expression of glutathione S-transferases in mouse liver. Toxicol. Sci.115(1), 22–33 (2010).
   PubMed Web of Science ®Google Scholar
• Gebhardt R. Metabolic zonation of the liver: regulation and implications for liver function. Pharmacol. Ther.53(3), 275–354 (1992).
   PubMed Web of Science ®Google Scholar
• Audard V, Grimber G, Elie C et al. Cholestasis is a marker for hepatocellular carcinomas displaying β-catenin mutations. J. Pathol.212(3), 345–352 (2007).
   PubMed Web of Science ®Google Scholar
• Behari J, Yeh TH, Krauland L et al. Liver-specific β-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitis. Am. J. Pathol.176(2), 744–753 (2010).
   PubMed Web of Science ®Google Scholar
• Yeh TH, Krauland L, Singh V et al. Liver-specific β-catenin knockout mice have bile canalicular abnormalities, bile secretory defect and intrahepatic cholestasis. Hepatology52(4), 1410–1419 (2010).
   PubMed Web of Science ®Google Scholar
• Amasheh S, Meiri N, Gitter AH et al. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J. Cell. Science115(Pt 24), 4969–4976 (2002).
   PubMed Web of Science ®Google Scholar
• Son S, Kojima T, Decaens C et al. Knockdown of tight junction protein claudin-2 prevents bile canalicular formation in WIF-B9 cells. Histochem. Cell Biol.131(3), 411–424 (2009).
   PubMed Web of Science ®Google Scholar
• Theard D, Steiner M, Kalicharan D, Hoekstra D, van Ijzendoorn SC. Cell polarity development and protein trafficking in hepatocytes lacking E-cadherin/β-catenin-based adherens junctions. Mol. Biol. Cell18(6), 2313–2321 (2007).
   PubMed Web of Science ®Google Scholar
• Nejak-Bowen KN, Zeng G, Tan X, Cieply B, Monga SP. β-catenin regulates vitamin C biosynthesis and cell survival in murine liver. J. Biol. Chem.284(41), 28115–28127 (2009).
   PubMed Web of Science ®Google Scholar
• Kondo Y, Inai Y, Sato Y et al. Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc. Natl Acad. Sci. USA103(15), 5723–5728 (2006).
   PubMed Web of Science ®Google Scholar
• Rubinfeld B, Souza B, Albert I et al. Association of the APC gene product with β-catenin. Science262(5140), 1731–1734 (1993).
   PubMed Web of Science ®Google Scholar
• Monga SP. Role of Wnt/β-catenin signaling in liver metabolism and cancer. Int. J. Biochem. Cell. Biol. DOI: 10.1016/j.biocel.2009.09.001 (2009) (Epub ahead of print).
   PubMedGoogle Scholar
• Takigawa Y, Brown AM. Wnt signaling in liver cancer. Curr. Drug Targets9(11), 1013–1024 (2008).
   PubMed Web of Science ®Google Scholar
• Cavard C, Colnot S, Audard V et al. Wnt/β-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology. Future Oncol.4(5), 647–660 (2008).
   PubMed Web of Science ®Google Scholar
• Ihara A, Koizumi H, Hashizume R, Uchikoshi T. Expression of epithelial cadherin and α- and β-catenins in nontumoral livers and hepatocellular carcinomas. Hepatology23(6), 1441–1447 (1996).
   PubMed Web of Science ®Google Scholar
• de La Coste A, Romagnolo B, Billuart P et al. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl Acad. Sci. USA95(15), 8847–8851 (1998).
   PubMed Web of Science ®Google Scholar
• Kondo Y, Kanai Y, Sakamoto M et al. β-catenin accumulation and mutation of exon 3 of the β-catenin gene in hepatocellular carcinoma. Jpn. J. Cancer Res.90(12), 1301–1309 (1999).
   PubMedGoogle Scholar
• Legoix P, Bluteau O, Bayer J et al. β-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity. Oncogene18(27), 4044–4046 (1999).
   PubMed Web of Science ®Google Scholar
• Wong CM, Fan ST, Ng IO. β-catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer92(1), 136–145 (2001).
   PubMed Web of Science ®Google Scholar
• Kim M, Lee HC, Tsedensodnom O et al. Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/β-catenin signaling pathway in hepatocellular carcinoma cells. J. Hepatol.48(5), 780–791 (2008).
   PubMed Web of Science ®Google Scholar
• Nhieu JT, Renard CA, Wei Y et al. Nuclear accumulation of mutated β-catenin in hepatocellular carcinoma is associated with increased cell proliferation. Am. J. Pathol.155(3), 703–710 (1999).
   PubMed Web of Science ®Google Scholar
• Huang H, Fujii H, Sankila A et al. β-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am. J. Pathol.155(6), 1795–1801 (1999).
   PubMed Web of Science ®Google Scholar
• Laurent-Puig P, Legoix P, Bluteau O et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology120(7), 1763–1773 (2001).
   PubMed Web of Science ®Google Scholar
• Cieply B, Zeng G, Proverbs-Singh T, Geller DA, Monga SP. Unique phenotype of hepatocellular cancers with exon-3 mutations in b-catenin gene. Hepatology49(3), 821–831 (2009).
   PubMed Web of Science ®Google Scholar
• Mao TL, Chu JS, Jeng YM, Lai PL, Hsu HC. Expression of mutant nuclear β-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis. J. Pathol.193(1), 95–101 (2001).
   PubMed Web of Science ®Google Scholar
• Hsu HC, Jeng YM, Mao TL et al. β-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am. J. Pathol.157(3), 763–770 (2000).
   PubMed Web of Science ®Google Scholar
• Yuzugullu H, Benhaj K, Ozturk N et al. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Mol. Cancer8, 90 (2009).
   PubMed Web of Science ®Google Scholar
• Toyama T, Lee HC, Koga H, Wands JR, Kim M. Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration. Mol. Cancer Res.8(2), 254–265 (2010).
   PubMed Web of Science ®Google Scholar
• Colnot S, Decaens T, Niwa-Kawakita M et al. Liver-targeted disruption of APC in mice activates β-catenin signaling and leads to hepatocellular carcinomas. Proc. Natl Acad. Sci. USA101(49), 17216–17221 (2004).
   PubMed Web of Science ®Google Scholar
• Cadoret A, Ovejero C, Terris B et al. New targets of β-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene21(54), 8293–8301 (2002).
   PubMed Web of Science ®Google Scholar
• Harada N, Miyoshi H, Murai N et al. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of β-catenin. Cancer Res.62(7), 1971–1977 (2002).
   PubMed Web of Science ®Google Scholar
• Zhang XF, Tan X, Zeng G et al. Conditional β-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor α/phosphoinositide 3-kinase signaling. Hepatology52(3), 954–965 (2010).
   PubMed Web of Science ®Google Scholar
• Lucero OM, Dawson DW, Moon RT, Chien AJ. A Re-evaluation of the “oncogenic” nature of Wnt/β-catenin signaling in melanoma and other cancers. Curr. Oncol. Rep.12(5), 314–318 (2010).
   PubMed Web of Science ®Google Scholar
• Behari J, Zeng G, Otruba W et al. R-etodolac decreases β-catenin levels along with survival and proliferation of hepatoma cells. J. Hepatol.46(5), 849–857 (2007).
   PubMed Web of Science ®Google Scholar
• Koch A, Denkhaus D, Albrecht S et al. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the β-catenin gene. Cancer Res.59(2), 269–273 (1999).
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Roberts LR, Aderca IN et al. Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene21(31), 4863–4871 (2002).
   PubMed Web of Science ®Google Scholar
• Wei Y, Fabre M, Branchereau S et al. Activation of β-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene19(4), 498–504 (2000).
   PubMed Web of Science ®Google Scholar
• Zimmermann A. The emerging family of hepatoblastoma tumours: from ontogenesis to oncogenesis. Eur. J. Cancer41(11), 1503–1514 (2005).
   PubMed Web of Science ®Google Scholar
• Cairo S, Armengol C, De Reynies A et al. Hepatic stem-like phenotype and interplay of Wnt/β-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell14(6), 471–484 (2008).
   PubMed Web of Science ®Google Scholar
• Bioulac-Sage P, Rebouissou S, Thomas C et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology46(3), 740–748 (2007).
   PubMed Web of Science ®Google Scholar
• Rebouissou S, Amessou M, Couchy G et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature457(7226), 200–204 (2009).
   PubMed Web of Science ®Google Scholar
• Rebouissou S, Couchy G, Libbrecht L et al. The β-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. J. Hepatol.49(1), 61–71 (2008).
   PubMed Web of Science ®Google Scholar
• Bioulac-Sage P, Laumonier H, Rullier A et al. Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int.29(3), 459–465 (2009).
   PubMed Web of Science ®Google Scholar
• Essers MA, de Vries-Smits LM, Barker N et al. Functional interaction between β-catenin and FOXO in oxidative stress signaling. Science308(5725), 1181–1184 (2005).
   PubMed Web of Science ®Google Scholar
• Funato Y, Michiue T, Asashima M, Miki H. The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-β-catenin signalling through dishevelled. Nat. Cell. Biol.8(5), 501–508 (2006).
   PubMed Web of Science ®Google Scholar
• Almeida M, Han L, Martin-Millan M, O’Brien CA, Manolagas SC. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting β-catenin from T cell factor- to forkhead box O-mediated transcription. J. Biol. Chem.282(37), 27298–27305 (2007).
   PubMed Web of Science ®Google Scholar
• Jiang F, Parsons CJ, Stefanovic B. Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. J. Hepatol.45(3), 401–409 (2006).
   PubMed Web of Science ®Google Scholar
• Cheng JH, She H, Han YP et al. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol.294(1), G39–G49 (2008).
   PubMed Web of Science ®Google Scholar
• Gebhardt R, Hovhannisyan A. Organ patterning in the adult stage: the role of Wnt/β-catenin signaling in liver zonation and beyond. Dev. Dyn.239(1), 45–55 (2010).
   PubMed Web of Science ®Google Scholar